The MR Neuroimaging Core, new to the ADRC in this competing renewal, serves two basic roles: l) MR imaging is an essential part of the clinical evaluation performed within the Clinical Core but the wealth of information available from the images has not until now been accessible to investigators for systematic review and quantitative analysis. The concept that the radiology report is an adequate summary of the image data is no longer tenable as quantitative morphometry has become technically feasible. Hence the Core provides the highest quality clinical study, systematic archiving of the image data and technological development of software tools for morphometric analyses. 2) MR techniques have evolved in terms of rapidity such that considerably more information than just high resolution anatomy can be obtained without prolongation of the MR examination time. These opportunities have been exploited by investigators elsewhere and the Core makes such tools available to investigators at this institution. These tools include IH spectroscopy with particular reference to quantitative measurement of N- acetyl metabolites such as N-acetyl aspartate, quantitative morphometry and functional MRI. The MR examination performed in vivo contains information that can be considered to be equivalent to the brain bank of the Neuropathology Core. The MR Neuroimaging Core is the repository for these image data and for the development of the tools for quantitative processing. As the MR technology evolves, the MR Neuroimaging Core implements new applications to acquire new information for ADRC investigators. As this is the mandate of the MR Research Program and involves no cost to the MR Neuroimaging Core, the ADRC capitalizes on the institutional investment in neuroimaging for ADRC investigators. Although this Core is closely connected to the Administrative, Clinical and Neuropathology Cores, the three Projects of Drs. Ferrell, Reynolds and Becker and the Pilot Project of Dr. Thulborn as well as other federally funded grants outside the ADRC, the full impact of this Core has yet to be made, given the recent formation of the MR Research Program at UPMC on which it is based.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005133-14
Application #
6234043
Study Section
Project Start
1997-05-01
Project End
1998-04-30
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
14
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Type
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Lopez, Oscar L; Becker, James T; Chang, YueFang et al. (2018) Amyloid deposition and brain structure as long-term predictors of MCI, dementia, and mortality. Neurology 90:e1920-e1928
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Tulloch, Jessica; Leong, Lesley; Chen, Sunny et al. (2018) APOE DNA methylation is altered in Lewy body dementia. Alzheimers Dement 14:889-894
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Zhao, Yujing; Tudorascu, Dana L; Lopez, Oscar L et al. (2018) Amyloid ? Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia. JAMA Neurol 75:88-96
Irimata, Katherine E; Dugger, Brittany N; Wilson, Jeffrey R (2018) Impact of the Presence of Select Cardiovascular Risk Factors on Cognitive Changes among Dementia Subtypes. Curr Alzheimer Res 15:1032-1044
Kaur, Antarpreet; Edland, Steven D; Peavy, Guerry M (2018) The MoCA-Memory Index Score: An Efficient Alternative to Paragraph Recall for the Detection of Amnestic Mild Cognitive Impairment. Alzheimer Dis Assoc Disord 32:120-124
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Brenowitz, Willa D; Han, Fang; Kukull, Walter A et al. (2018) Treated hypothyroidism is associated with cerebrovascular disease but not Alzheimer's disease pathology in older adults. Neurobiol Aging 62:64-71

Showing the most recent 10 out of 667 publications